ZA200701612B - Cyclopropyl piperidine glycine transporter inhibitors - Google Patents
Cyclopropyl piperidine glycine transporter inhibitorsInfo
- Publication number
- ZA200701612B ZA200701612B ZA200701612A ZA200701612A ZA200701612B ZA 200701612 B ZA200701612 B ZA 200701612B ZA 200701612 A ZA200701612 A ZA 200701612A ZA 200701612 A ZA200701612 A ZA 200701612A ZA 200701612 B ZA200701612 B ZA 200701612B
- Authority
- ZA
- South Africa
- Prior art keywords
- glycine transporter
- cyclopropyl piperidine
- transporter inhibitors
- piperidine glycine
- cyclopropyl
- Prior art date
Links
- 102000010726 Glycine Plasma Membrane Transport Proteins Human genes 0.000 title abstract 3
- 108010063380 Glycine Plasma Membrane Transport Proteins Proteins 0.000 title abstract 3
- JUBXTBVKELTJEX-UHFFFAOYSA-N 1-cyclopropylpiperidine Chemical compound C1CC1N1CCCCC1 JUBXTBVKELTJEX-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 102100023145 Sodium- and chloride-dependent glycine transporter 1 Human genes 0.000 abstract 2
- 101710083171 Sodium- and chloride-dependent glycine transporter 1 Proteins 0.000 abstract 2
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 230000024587 synaptic transmission, glutamatergic Effects 0.000 abstract 1
- 230000027682 synaptic transmission, glycinergic Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61494204P | 2004-09-30 | 2004-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200701612B true ZA200701612B (en) | 2009-05-27 |
Family
ID=36142986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200701612A ZA200701612B (en) | 2004-09-30 | 2007-02-23 | Cyclopropyl piperidine glycine transporter inhibitors |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7776886B2 (de) |
| EP (1) | EP1797035B1 (de) |
| JP (1) | JP4646984B2 (de) |
| KR (1) | KR20070058565A (de) |
| CN (1) | CN101031547A (de) |
| AT (1) | ATE488501T1 (de) |
| AU (1) | AU2005292323B2 (de) |
| BR (1) | BRPI0515954A (de) |
| CA (1) | CA2581582C (de) |
| DE (1) | DE602005024838D1 (de) |
| IL (1) | IL182253A0 (de) |
| MX (1) | MX2007003816A (de) |
| NO (1) | NO20072208L (de) |
| RU (1) | RU2387644C2 (de) |
| WO (1) | WO2006039221A2 (de) |
| ZA (1) | ZA200701612B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070105902A1 (en) * | 2003-11-12 | 2007-05-10 | Lindsley Craig W | 4-Phenyl piperdine sulfonyl glycine transporter inhibitors |
| US7825135B2 (en) * | 2004-03-24 | 2010-11-02 | Merck Sharp & Dohme Limited | Heteroaryl piperidine glycine transporter inhibitors |
| AU2005243192A1 (en) * | 2004-04-29 | 2005-11-24 | Merck & Co., Inc. | Azetidine glycine transporter inhibitors |
| US7576083B2 (en) * | 2004-05-05 | 2009-08-18 | Merck & Co., Inc. | Morpholinyl piperidine glycine transporter inhibitors |
| EP1831201B1 (de) * | 2004-12-21 | 2010-08-04 | Merck Sharp & Dohme Ltd. | Piperidin- und azetidinderivate als glyt1-inhibitoren |
| WO2006131711A1 (en) * | 2005-06-06 | 2006-12-14 | Merck Sharp & Dohme Limited | Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| CA2611376C (en) | 2005-06-13 | 2013-09-10 | Merck Sharp & Dohme Limited | Therapeutic agents |
| JP5175736B2 (ja) * | 2005-10-28 | 2013-04-03 | メルク・シャープ・エンド・ドーム・コーポレイション | ピペリジングリシン輸送体阻害剤 |
| US8431700B2 (en) | 2009-03-03 | 2013-04-30 | Vanderbilt University | Alkylsulfonyl-2,3-dihydrospiro[indene-1,4′-piperidine] analogs as GlyT1 inhibitors, methods for making same, and use of same in treating psychiatric disorders |
| EP3134406A1 (de) | 2014-04-24 | 2017-03-01 | Dart Neuroscience (Cayman) Ltd | Substituierte 2,4,5,6-tetrahydropyrrolo [ 3,4-c ] pyrazol-und 4,5,6,7-tetrahydro-2 h-pyrazolo [ 4,3-c ] pyridinverbindungen als glyt1-inhibitoren |
| US10040759B2 (en) | 2014-11-05 | 2018-08-07 | Dart Neuroscience (Cayman) Ltd. | Substituted azetidinyl compounds as GlyT1 inhibitors |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5532237A (en) | 1995-02-15 | 1996-07-02 | Merck Frosst Canada, Inc. | Indole derivatives with affinity for the cannabinoid receptor |
| US6303637B1 (en) * | 1998-10-30 | 2001-10-16 | Merck & Co., Inc. | Heterocyclic potassium channel inhibitors |
| EP1263729B1 (de) * | 2000-03-06 | 2006-12-20 | Acadia Pharmaceuticals Inc. | Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten |
| EP1268449A4 (de) * | 2000-03-23 | 2004-09-15 | Merck & Co Inc | Substituierte piperidine als melanokortin-rezeptor-agonisten |
| US7507767B2 (en) | 2001-02-08 | 2009-03-24 | Schering Corporation | Cannabinoid receptor ligands |
| JP2005509032A (ja) * | 2001-11-14 | 2005-04-07 | シェーリング コーポレイション | カンナビノイドレセプターリガンド |
| GB0130696D0 (en) * | 2001-12-21 | 2002-02-06 | Smithkline Beecham Plc | Chemical Compounds |
| TW200403058A (en) | 2002-04-19 | 2004-03-01 | Bristol Myers Squibb Co | Heterocyclo inhibitors of potassium channel function |
| US20070105902A1 (en) * | 2003-11-12 | 2007-05-10 | Lindsley Craig W | 4-Phenyl piperdine sulfonyl glycine transporter inhibitors |
| US7825135B2 (en) * | 2004-03-24 | 2010-11-02 | Merck Sharp & Dohme Limited | Heteroaryl piperidine glycine transporter inhibitors |
| AU2005243192A1 (en) * | 2004-04-29 | 2005-11-24 | Merck & Co., Inc. | Azetidine glycine transporter inhibitors |
| US7576083B2 (en) * | 2004-05-05 | 2009-08-18 | Merck & Co., Inc. | Morpholinyl piperidine glycine transporter inhibitors |
| EP1831201B1 (de) | 2004-12-21 | 2010-08-04 | Merck Sharp & Dohme Ltd. | Piperidin- und azetidinderivate als glyt1-inhibitoren |
| WO2006131711A1 (en) * | 2005-06-06 | 2006-12-14 | Merck Sharp & Dohme Limited | Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| ES2382818T3 (es) | 2005-09-29 | 2012-06-13 | Merck Sharp & Dohme Corp. | Inhibidores de transportadores glicina radiomarcados |
| JP5175736B2 (ja) | 2005-10-28 | 2013-04-03 | メルク・シャープ・エンド・ドーム・コーポレイション | ピペリジングリシン輸送体阻害剤 |
-
2005
- 2005-09-26 BR BRPI0515954-7A patent/BRPI0515954A/pt not_active IP Right Cessation
- 2005-09-26 DE DE602005024838T patent/DE602005024838D1/de not_active Expired - Lifetime
- 2005-09-26 EP EP05801197A patent/EP1797035B1/de not_active Expired - Lifetime
- 2005-09-26 AT AT05801197T patent/ATE488501T1/de not_active IP Right Cessation
- 2005-09-26 CN CNA2005800331179A patent/CN101031547A/zh active Pending
- 2005-09-26 JP JP2007534679A patent/JP4646984B2/ja not_active Expired - Fee Related
- 2005-09-26 RU RU2007116165/04A patent/RU2387644C2/ru not_active IP Right Cessation
- 2005-09-26 WO PCT/US2005/034301 patent/WO2006039221A2/en not_active Ceased
- 2005-09-26 CA CA2581582A patent/CA2581582C/en not_active Expired - Lifetime
- 2005-09-26 US US11/664,190 patent/US7776886B2/en active Active
- 2005-09-26 KR KR1020077007362A patent/KR20070058565A/ko not_active Withdrawn
- 2005-09-26 AU AU2005292323A patent/AU2005292323B2/en not_active Ceased
- 2005-09-26 MX MX2007003816A patent/MX2007003816A/es active IP Right Grant
-
2007
- 2007-02-23 ZA ZA200701612A patent/ZA200701612B/xx unknown
- 2007-03-27 IL IL182253A patent/IL182253A0/en unknown
- 2007-04-27 NO NO20072208A patent/NO20072208L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE488501T1 (de) | 2010-12-15 |
| RU2387644C2 (ru) | 2010-04-27 |
| AU2005292323A1 (en) | 2006-04-13 |
| US7776886B2 (en) | 2010-08-17 |
| EP1797035A4 (de) | 2009-08-05 |
| JP4646984B2 (ja) | 2011-03-09 |
| IL182253A0 (en) | 2007-09-20 |
| WO2006039221A2 (en) | 2006-04-13 |
| AU2005292323B2 (en) | 2011-06-09 |
| CA2581582C (en) | 2010-07-20 |
| JP2008514705A (ja) | 2008-05-08 |
| NO20072208L (no) | 2007-04-27 |
| CA2581582A1 (en) | 2006-04-13 |
| WO2006039221A3 (en) | 2006-09-08 |
| EP1797035A2 (de) | 2007-06-20 |
| CN101031547A (zh) | 2007-09-05 |
| BRPI0515954A (pt) | 2008-08-12 |
| RU2007116165A (ru) | 2008-11-10 |
| DE602005024838D1 (en) | 2010-12-30 |
| KR20070058565A (ko) | 2007-06-08 |
| US20080108663A1 (en) | 2008-05-08 |
| EP1797035B1 (de) | 2010-11-17 |
| MX2007003816A (es) | 2007-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL182253A0 (en) | Cyclopropyl piperidine glycine transporter inhibitors | |
| WO2005046601A3 (en) | 4-phenyl piperdine sulfonyl glycine transporter inhibitors | |
| HUS2100051I1 (hu) | Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére | |
| WO2005094514A3 (en) | Heteroaryl piperidine glycine transporter inhibitors | |
| TW200602052A (en) | Azaindoles useful as inhibitors of JAK and other protein kinases | |
| WO2007020103A3 (en) | Novel use of peptide compounds for treating muscle pain | |
| SG151327A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
| TW200531689A (en) | Therapeutic agents | |
| TW200800976A (en) | New compounds for the treatment of neurological, psychiatric or pain disorders | |
| WO2007104053A3 (en) | 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders | |
| WO2007025069A3 (en) | Diazaspirodecane orexin receptor antagonists | |
| TW200630090A (en) | Triazoles useful as inhibitors of protein kinases | |
| TW200621716A (en) | Novel compounds | |
| ATE494890T1 (de) | Alpha-aminoamid-derivate zur behandlung von suchtstörungen | |
| TW200724140A (en) | Hydantoin compounds | |
| WO2007053400A3 (en) | Piperidine glycine transporter inhibitors | |
| TW200611701A (en) | Novel compounds | |
| UA85471C2 (ru) | Применение оксикодона для лечения висцеральной боли | |
| IL184355A0 (en) | Sulfanyl substituted phenyl methanones as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders | |
| WO2005107469A3 (en) | Morpholinyl piperidine glycine transporter inhibitors | |
| WO2005117939A3 (en) | Use of GPCR54 ligands for the treatment of infertility | |
| IL162154A0 (en) | Prostagandin composition for the treatment of erectile dysfunction | |
| ATE314043T1 (de) | Derivate von aza-spiroverbindungen zur behandlung von schmerzen | |
| EA200800342A1 (ru) | ИНГИБИТОРЫ Glepp-1 ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И/ИЛИ ВОСПАЛИТЕЛЬНЫХ РАССТРОЙСТВ | |
| WO2007076318A3 (en) | Camphor-derived cxcr3 antagonists |